Viewing Study NCT06891560


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-28 @ 12:01 AM
Study NCT ID: NCT06891560
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module